Document is current
Any future updates will be listed below
-
Authors
Pozo-Beltran, Cesar Fireth https://orcid.org/0000-0002-8282-1851
Elizondo-Villarreal, Barbara https://orcid.org/0000-0002-8499-8263
Morett-Vera, Fernando https://orcid.org/0000-0002-1040-0329
Gonzalez-Uribe, Victor https://orcid.org/0000-0001-9053-7108
Rodriguez-Romo, Roxana Minerva https://orcid.org/0000-0002-4387-4985
Navarrete-Rodriguez, Elsy Maureen https://orcid.org/0000-0001-9876-3206
Paniagua-Santos, Jorge Andres https://orcid.org/0000-0001-6418-8792
Ledezma-Ortega, Jesus Fernando https://orcid.org/0000-0001-9306-8730
Briceño-Gamboa, Adriana Virginia https://orcid.org/0000-0003-2235-4144
- License Information
-
More Information
Article History
Accepted: 24 April 2023
First Online: 11 October 2023
<!--Emphasis Type='Bold' removed-->Compliance with Ethical Standards
:
: Dr. Cesar Fireth-Pozo Beltran has received consulting fees and honoraria for continuing education from AstraZeneca, GlaxoSmithKline, Alergia Molecular, Sanofi, Inmunotek SL, and Nestle. Dra. Barbara Elizondo-Villarreal has received consulting fees and honoraria for continuing education from AstraZeneca. Dra. Roxana Minerva Rodriguez-Romo works as medical advisor for AstraZeneca. Dr. Fernando Morett-Vera has received fees and honoraria for continuing education from AstraZeneca, Chiesi, GlaxoSmithKline, and Janssen. Dr. Victor Gonzalez-Uribe has received consulting fees and honoraria for continuing education from ALK, Sanofi, M8, and Bayer. Dra. Elsy Maureen Navarrete-Rodriguez has received consulting fees and honoraria for continuing education from AstraZeneca, GlaxoSmithKline, and Sanofi. Dr. Jesus Fernando-Ledezma Ortega, Dra. Adriana Virginia Briceño-Gamboa, and Dr. Jorge Andres Paniagua-Santos have no conflict of interest. All the authors have declared that they do not have financial interest directly or indirectly related for this publication.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
